Radiology Business

SEPTEMBER 20, 2023

Backers include societies representing radiologists and nuclear medicine professionals, device manufacturers, patient advocacy groups, and pharmaceutical companies.

Nuclear Medicine 101

Nuclear Medicine Pharmaceutical Diagnostic Imaging Diagnostic 101

AuntMinnie

JUNE 3, 2024

Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology.

Nuclear Medicine 105

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 105

Open Medscience

JANUARY 12, 2024

Radiopharmaceuticals, combining radioactive and pharmaceutical elements, enable precise diagnosis and treatment in nuclear medicine. The post The Transformative Impact of Radiopharmaceuticals in Medical Imaging appeared first on Open Medscience.

Radiopharmaceuticals 52

Radiopharmaceuticals Medical Imaging Nuclear Medicine Medical 52

AuntMinnie

JUNE 10, 2024

Evans, PhD, has been named the 2024 recipient of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Sam Gambhir Trailblazer Award. He has also co-founded, consulted, and/or served on the scientific advisory board of several biotech companies, including Oric Pharmaceuticals, Enlaza Therapeutics, and HoneyBear Biosciences.

Nuclear Medicine 40

Nuclear Medicine Radiopharmaceuticals Pharmaceutical Clinic 40

Imaging Technology

JUNE 19, 2023

Scholz continued, “On behalf of the entire Company, we want to express our sincere appreciation to Steve Merrick, who, in his seven years of commitment and strategic leadership, has advanced NorthStar’s innovation and radiopharmaceutical expertise to the forefront of nuclear medicine. Frank Scholz, Ph.D., He holds a Ph.D.

Medical 77

Medical Pharmaceutical Radiopharmaceuticals Nuclear Medicine 77

Imaging Technology

JUNE 15, 2023

For pharmaceutical companies and researchers, using this tracer to better understand the mechanism of action - i.e. the effect of immunotherapies on a patient’s immune response to their cancer - could, potentially, enable them to better select patients to participate in clinical trials and bring new immunotherapies to market.

Radiopharmaceuticals 84

Radiopharmaceuticals Pharmaceutical Nuclear Medicine PET Scan 84

Imaging Technology

APRIL 13, 2023

Earlier in his career, he held operational responsibilities for facility management of isotope production with Regional Nuclear Pharmaceuticals (now Cardinal Health). NorthStar has an industry-leading reputation based on its technological innovation, successful execution and proven expertise. SPECT franchise.

Radiopharmaceuticals 69

Radiopharmaceuticals Medical Pharmaceutical Nuclear Medicine 69